Clinical trials of the drug have been conducted since June 18. The volunteers will soon be discharged from the hospital.
The coronavirus pandemic remains a topic of concern to many. People are anxiously waiting for a vaccine to help stop the spread of the disease.
On July 12, Vadim Tarasov, director of the Institute of Translational Medicine and Biotechnology at Sechenov University, announced that trials of the world’s first drug, which had been underway for almost a month, had come to an end. The vaccine was developed by scientists from the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya.
“The safety of the vaccine has been confirmed. It is consistent with the safety of those vaccines currently on the market and used in humans. Therefore, in my opinion, this stage went very well, “said Alexander Lukashev, director of the Institute of Medical Parasitology, Tropical and Vector-borne Diseases of Sechenov University, in a conversation with .
The first group of volunteers will go home on July 15th, and the second on the 20th. According to the scientist, the isolation affected their psychological state. Conflicts arose between them, the level of emotional stress increased markedly. So it was not done without the help of psychologists during the tests.
All discussions of the coronavirus on the Healthy Food Near Me forum.